Original ARB Fimasartan FDF (Kanarb)

Original ARB Fimasartan FDF (Kanarb)

Cardiovascular system

Information

Kanarb is the No.1 amongst ARBs available on the market in Korea. Globally, we have business partnership for this product in 51 countries worldwide, that implies that Kanarb is being recognized internationally. - Fimasartan-containing combination drugs available as well Fimasartan+HCTZ, Fimasartan+Amlodipine, Fimasartan+Rosuvastatin Fimasartan+Amlodipine+HCTZ, Fimasartan+Amlodipine+Rosuvasatin Fimasartan showed superior effect in lowering BP and significantly higher response rate when compared with Losartan and Valsartan in our clinical studies
Boryung Pharmaceutical  About Boryung Pharmaceutical Co.,Ltd.  Established in 1957, Boryung Pharmaceutical Company has put a strong presence in the Korean market as one of TOP leading pharmaceutical companies.  [World 8th Original ARBs drug] Kanarb is the No.1 amongst ARBs available on the market in Korea. Globally, we have business partnership for this product in 51 countries worldwide, that implies that Kanarb is being recognized internationally.     [Introduction of oncology business with Boryung]  Boryung pharmaceutical could become#1 oncology company through the robust quality of all of our oncology injections for many years.  User satisfaction is guaranteed as our oncology sales revenue in local market are more than $100 Mil. (Company Revenue is more than $500 Mil, as a group $800 Mil)  Moreover, our company has built a state of the art new oncology plant in 2019 that can reduce production costs.  

Join the event!